IP Library Granted Patent US 8,821,859
Granted Patent B2
US 8,821,859 · App. 10/849,498 · Granted Sep 2, 2014

Methods and articles for the delivery of therapeutic agents

Inventors: Yi-Yan Yang (Singapore, SG); Yong Wang (Singapore, SG); Cherng-wen Tan (Singapore, SG); Jackie Y. Ying (Singapore, SG)
Assignee: Agency for Science, Technology and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,821,859
App. No.
10/849,498
Granted
Sep 2, 2014
Kind
B2
Abstract

Articles and methods for the delivery of drugs and/or nucleic acids. Articles including a nanoparticle are provided that may be used for the delivery of a drug, a nucleic acid, or both, to a subject. The articles may be of polymeric material and may self-assemble.

Claims (27)

1. An article for delivering a drug and a nucleic acid, the article comprising:

a nanoparticle micelle, wherein the nanoparticle comprises a polymer having a polyester backbone comprising N-methyldietheneamine sebacate and [(cholesteryl oxocarbonylamido ethyl) methyl bis (ethylene) ammonium bromide] sebacate;

a nucleic acid associated with an exterior of the micelle; and

a drug associated with an interior of the micelle.

2. The article of claim 1 , wherein the nanoparticle is capable of passing through a cell membrane.

3. The article of claim 1 , wherein the nucleic acid is DNA.

4. The article of claim 1 , wherein the drug is a cancer drug.

5. The article of claim 1 , wherein the nanoparticle is stable at a concentration of greater than 5 mg/L.

6. The article of claim 1 , wherein the nanoparticle is capable of crossing the blood/brain barrier.

7. A composition comprising the article of claim 1 and a pharmaceutically acceptable carrier.

8. The article of claim 1 , wherein the polyester backbone comprises tertiary amines.

9. The article of claim 8 , wherein the polyester backbone comprises a copolymer of quaternized and non-quaternized tertiary ammonium groups.

10. The article of claim 1 , wherein the polyester backbone further comprises an ether linkage.

11. The article of claim 8 , wherein at least a portion of the tertiary amines are quaternized and bound to a hydrophobic side chain.

12. The article of claim 1 , wherein the polyester backbone further comprises a polyether.

13. A kit comprising:

a container including an amphoteric polymeric nanoparticle micelle, wherein the polymeric nanoparticle comprises a polymer having a polyester backbone comprising N-methyldietheneamine sebacate and [(cholesteryl oxocarbonylamido ethyl) methyl bis (ethylene) ammonium bromide] sebacate;

a nucleic acid associated with an exterior of the micelle;

a drug associated with an interior of the micelle; and

instructions for administering the nanoparticle to a subject.

14. The kit of claim 13 , wherein the polyester backbone comprises a graft co-polymer.

15. The article of claim 1 , wherein the polyester backbone comprises an amphiphilic co-polymer.

16. The article of claim 15 , wherein the amphiphilic co-polymer is a cationic amphiphilic co-polymer.

17. The article of claim 1 , wherein the drug is not covalently or ionically bound to the nanoparticle.

18. The article of claim 1 , wherein the drug is physically contained by the nanoparticle.

19. The article of claim 1 , wherein the polyester backbone comprises a graft co-polymer.

20. The article of claim 11 , wherein the hydrophobic side chain comprises cholesterol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2004
From: YANG, YI-YAN; WANG, YONG; TAN, CHERNG-WEN DARREN; YING, JACKIE Y.
To: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Reel/Frame 015366/0820 →
Continuity (1)
Related Publication 20050260276A1 · Nov 24, 2005